Joe Wiley, CEO of Amryt Pharma discusses their $40m Private Placement with Leading Biotech Investors
Episode 92, Dec 09, 2020, 01:44 PM
Joe Wiley, CEO of Amryt Pharma #AMYT discusses their $40m Private Placement with Leading Biotech Investors and how being listed on NASDAQ has increased interest in the company.